Ocera Completes Interim Analysis of OCR-002 in Phase 2b STOP-HE Study; Nymox Announces Phase 3 BPH Studies Print E-mail
By Marilyn Mullen   
Wednesday, 01 April 2015 21:10
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 1, 2015.
Read more...
 
Ocata Successfully Completes Dosing in Phase 1/2 RPE Studies; Capricor Completes Enrollment of Phase II Clinical Trial for Cenderitide Print E-mail
By William Kent   
Tuesday, 31 March 2015 19:33
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 31, 2015.
Read more...
 
The Medicines Company Receives European Commission Approval for Three Products; Europe Deal Coming For Orexigen Print E-mail
By William Kent   
Tuesday, 31 March 2015 00:00
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 30, 2015.
Read more...
 
Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study; pSivida Completes Targeted Enrollment of Phase III Trial of Medidur Print E-mail
By Marilyn Mullen   
Thursday, 26 March 2015 19:01
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 26, 2015.
Read more...
 
VBL Therapeutics Reports Interim Topline Results From Phase 2 Clinical Trial of VB-111; Vical Expands Infectious Disease Portfolio With Novel Antifungal Print E-mail
By William Kent   
Wednesday, 25 March 2015 18:45
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 25, 2015.
Read more...
 
Vertex Treatment May Have High Risk of Failure; Agios Announces Orphan Drug Designation of AG-348 Print E-mail
By Josh Gee   
Tuesday, 24 March 2015 18:56
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 24, 2015.
Read more...
 
Vertex Pharma's Disappointing VX-661 Trial Results Isn't The End; Arch Therapeutics Announces Positive Safety Results for AC5 Surgical Hemostatic Device(TM) Print E-mail
By Marilyn Mullen   
Monday, 23 March 2015 19:13
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 23, 2015.
Read more...
 
AstraZeneca And Daiichi Sankyo To Jointly Commercialise MOVANTIK; Amicus Provides Positive Global Regulatory Updates for Fabry Monotherapy Print E-mail
By Marilyn Mullen   
Thursday, 19 March 2015 18:49
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 19, 2015.  
Read more...
 
Actinium Announces New Data from Ongoing Phase 1/2 Trial of Actimab-A; NEMUS initiates anti-infective program Print E-mail
By William Kent   
Wednesday, 18 March 2015 18:46
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 18, 2015.  
Read more...
 
Applied DNA Sciences Announces SigNature DNA Compliance With FDA Guidelines; Myriad and BioMarin Expand Collaboration to Evaluate Talazoparib Print E-mail
By William Kent   
Tuesday, 17 March 2015 18:50
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 17, 2015. 
Read more...
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 12 of 369

Newsletter